DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹2,191 Cr | ₹1,600 Cr | ₹1,824 Cr | ₹2,960 Cr | ₹1,984 Cr |
What is the latest Profit After Tax of DIVIS LABORATORIES ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹2,191 Cr |
| Mar2024 | ₹1,600 Cr |
| Mar2023 | ₹1,824 Cr |
| Mar2022 | ₹2,960 Cr |
| Mar2021 | ₹1,984 Cr |
How is Profit After Tax of DIVIS LABORATORIES Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,191 Cr | 36.94 | |
| Mar2024 | ₹1,600 Cr | -12.28 | |
| Mar2023 | ₹1,824 Cr | -38.39 | |
| Mar2022 | ₹2,960 Cr | 49.19 | |
| Mar2021 | ₹1,984 Cr | - | |
Compare Profit After Tax of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹164,846.3 Cr | -3.9% | -6% | 11.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,559.0 Cr | 1.2% | -5.3% | -5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,942.0 Cr | 0.9% | 3.7% | 20.5% | Stock Analytics | |
| CIPLA | ₹106,825.0 Cr | -1.2% | -12.6% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,077.0 Cr | -3.4% | -5.7% | 0.3% | Stock Analytics | |
| MANKIND PHARMA | ₹88,996.6 Cr | -2.3% | -4.4% | -14.9% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -3.9% |
-6% |
11.9% |
| SENSEX | 1.7% |
-1.7% |
10.3% |
You may also like the below Video Courses